Profile image
By ETF Daily News (Reporter)
Contributor profile | More stories
Story Views
Now:
Last Hour:
Last 24 Hours:
Total:

Will Shares of Canopy Growth (CGC) Sink or Swim?

% of readers think this story is Fact. Add your two cents.


From Eric Bowler

A lot of mixed news has been swirling around Canopy Growth Corp. (CGC) lately, so it’s worth taking a deeper dive to see how well this stock can stay afloat. 

Starting with the elephant in the room, many investors still seem shaken by the void in leadership left behind former CEO Bruce Linton’s wake. However, interim CEO Mark Zekulin seems confident that they’ll have Linton’s replacement within “a matter of months.”

“But it’s not about Bruce, it’s not about Mark and as excited as we are about the next CEO, it’s not even about that person, right?” Zelulin said. 

“It is about the fact that we built a company of 4,000 people who all believe in a culture, a mission, that there is a multi-hundred-billion-dollar opportunity to seize. And that commitment, that team, that structure existed yesterday, it exists today, and will exist tomorrow.”

Following the steep downhill trend that plagued cannabis stocks throughout the summer, CGC stock seems to finally be regaining some footing as its value spiked up approximately 15% in recent weeks.  

Will Rec. 2.0 be the game changer? 

Many investors are looking to Rec 2.0 to be a game changer in the Canadian market. Rec 2.0 is the informal name for when the Canadian government legalizes the sale of new cannabis product lines (such as edibles) later this year. Amongst its Canadian peers, Canopy Growth is poised to capitalize on this, with plans to launch edibles, beverages and vape products. 

Canopy Growth also has jumbo size working in its favor. With 5 million square feet in licensed capacity across multiple countries, CGC has already set itself up to be a dominant player in the global market. 

Nonetheless, expansion has not been cheap and losses have been piling up regardless of the company’s 249% increase in revenue year on year. This pace of supply expansion increases a higher loss per share, as revenue continues to lag behind costs.

Many investors are confident that Canopy will eventually achieve economies of scale as it expands in multiple countries. But in order to get there, the company must also balance supply levels with the actual demand that comes with product legalization.

Canopy Growth also touts the ambitious goal of achieving a $1 billion run rate by the fourth quarter with a 40% margin. Even if Canadian demand isn’t quite there yet, CGC seems certain that it will be soon. 

Currently, there are approximately 460-600 cannabis retail stores open throughout Canada, however it’s expected that Canada will see another 1,500 more stores open throughout the next few years, which CGC is banking on. Not only that, it’s important to keep in mind that Canopy’s aggressive rate run target is aimed at a global market, not just the Canadian one.  

Nonetheless, Canopy’s strategy to build inventory first and optimize output, has hurt short-term results. The gross margins of 15-22% fell short of the target, but are primarily attributed to retrofitting activities that hurt yield. The company claims these issues have been resolved, and anticipates getting back to the 40% margin rate by Q4/2020.

Also, keep in mind that CGC is still sitting on approximately $3 billion left from the Constellation (STZ) investment (and that Constellation has majority control). The company’s war chest will most likely be used to cover expenses related to integrating Acreage and C3 (a division of Bionorica). 

CGC has already spent hundreds of millions developing its bottling facility and advanced manufacturing building in Canada.


Canopy Growth Corp. (CGC) was trading at $27.65 per share on Wednesday morning, up $0.22 (+0.80%). Year-to-date, CGC has declined N/A%, versus a 12.55% rise in the benchmark S&P 500 index during the same period.


This article is brought to you courtesy of ETFDailyNews.com.


About the Author: Eric Bowler

eric-bowlerEric Bowler is an accomplished journalist providing in-depth insights for more than two decades. Over the past several years his focus has been on the marijuana industry, with a special interest in cannabis growth stocks. His daily coverage of the industry keeps him on top of the key trends with the goal of helping investors make well-informed decisions.

You are viewing an abbreviated republication of ETF Daily News content. You can find full ETF Daily News articles on (www.etfdailynews.com)

The post Will Shares of Canopy Growth (CGC) Sink or Swim? appeared first on ETF Daily News.



Source: https://etfdailynews.com/2019/09/11/will-shares-of-canopy-growth-cgc-sink-or-swim/

Support BeforeitsNews by trying our natural health products! Join our affiliate program
Order by Phone at 888-809-8385 or online at www.mitocopper.com


Get our Free Ebook, "Suppressed Health Secrets"  with  Natural Cures THEY don't want you to know!

APeX - Far superior to colloidal silver!  Destroys Viruses, Bacteria, Pathogens with Oxygen plus Silver!Supreme Fulvic - Nature's most important supplement! Vivid Dreams again!
Ultimate Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen!  
Organic Hemp Extract (CBD) - Full Spectrum high CBD (3300mg) hemp extract eases stiff joints, relieves stress and more!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.

Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)


FINAL WARNING!   Diseases are EXPLODING!  Watch this Video about APeX and You'll THROW AWAY Your Colloidal Silver!   APeX destroys Viruses, Bacteria and other Pathogens with the power of Oxygen PLUS Silver!  Nobody else has a product like THIS!   See why the inventor hasn't been sick in 16 years and why you'll never hear about it on the FAKE NEWS!  Get some now and tell your friends about it too so we can reach more people!  

APeX Interview - Superior to Colloidal Silver from Lee Canady on Vimeo.

Learn about APeX Here and Get the 50 Page Report in PDF format.   Call us at 888-809-8385 to order by phone.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.